• Skip to main content
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Research and Innovation: Institutional Review Board
  • UAMS Health
  • Jobs
  • Giving
  • About
    • Compliance Statement
    • Full Board Meetings
      • Committee Rosters
    • Institutional Review Board Blogs
    • Institutional Review Board Staff
    • Join the UAMS Institutional Review Board
    • Review Fees
  • CLARA
    • Access the System
    • Request a Human Subjects Research Determination
    • Start a Study
  • Templates, Training and Tools
    • Consent for Non-English Speakers
    • Events and Deviations Tables
    • Expanded Access Programs: Compassionate Use & Emergency Use
    • Human Subject Protection Training Instructions
  • Reporting to the Institutional Review Board
  • Expanded Access
  • Institutional Review Board Policies
    • Current Institutional Review Board Policies
      • 1 Principles and Authority
      • 2 Relationships
      • 3 Committee Membership
      • 4 Institutional Review Board Operations
      • 5 Records (Retired)
      • 6 Documentation
      • 7 Procedures for Study Review
      • 8 Change in Protocol
      • 9 Institutional Review Board Decisions
      • 10 Principal Investigator Responsibilities
      • 11 Appeals and Reconsiderations (retired)
      • 12 Quality Assurances
      • 13 Confidentiality
      • 14 Recruitment Practices
      • 15 Consent
      • 16 Risk / Benefit Analysis (moved)
      • 17 Special Populations
      • 18 Drugs and Devices
      • 19 Human Genetics Guidance
      • 20 Questions, Concerns, Suggestions and Complaints
    • Institutional Review Board Policy Archives
      • 1 Principles and Authority Archive
      • 2 Relationships Archive
      • 3 Committee Membership Archive
      • 4 Institutional Review Board Operations Archive
      • 5 Records Archive
      • 6 Documentation Archive
      • 7 Procedures for Study Review Archive
      • 8 Change in Protocol Archive
      • 9 Institutional Review Board Decisions Archive
      • 10 Principal Investigator Responsibilities Archive
      • 11 Appeals and Reconsiderations Archive
      • 12 Quality Assurances Archive
      • 13 Confidentiality Archive
      • 14 Recruitment Practices Archive
      • 15 Consent Archive
      • 16 Risk / Benefit Analysis Archive
      • 17 Special Populations Archive
      • 18 Drugs and Devices Archive
      • 19 Human Genetics Guidance Archive
      • 20 Questions, Concerns, Suggestions, Complaints Archive
  • Research Resources
    • Acronyms and Resources
    • FAQs
      • CITI Program FAQs
      • CLARA FAQs
      • Does my project need IRB review?
      • Prereview and Review Process FAQs
      • Reporting FAQs
      • Submission FAQs
    • Single / Central Institutional Review Board Review
  • Human Research Protection Program Plan
  1. University of Arkansas for Medical Sciences
  2. Research and Innovation
  3. Institutional Review Board
  4. Author: Edith Paal
  5. Page 20

Edith Paal

(Slightly) Revised IRB Policy 8.1 on modifications posted

A revised IRB Policy 8.1, titled “Modifications to Previously Approved Research,” is hot off the presses and posted on the IRB’s website. The changes are mostly formatting related, although we did make a few minor content changes (e.g. we don’t, in fact, require a copy of the updated FDA Form 1572 with a PI change […]

Filed Under: Institutional Review Board Members

HSR determination form changes to facilitate HIPAA authorization waivers

The IRB has revised its human subject research determination form to make it easier to request HIPAA authorization waivers for research projects using material subject to HIPAA, but which aren’t really identifiable as far as the human subject research regulations are concerned. Let us explain. One thing that has long gotten our collective goat is […]

Filed Under: Institutional Review Board Members

Updated IRB Policies posted

The IRB scribes have been hard at work updating the IRB policies to ensure they meet current regulatory and accrediting agency requirements, add references, and make them easier to read. New policies posted in recent days are: IRB Policy 2.3, Single/Central IRBs IRB Policy 3.2, Quorum IRB Policy 3.6, IRB Members and Alternates. Note that […]

Filed Under: Institutional Review Board Members

Parental signatures on pediatric studies informed consent/permission forms

Federal regulations and IRB policies require the IRB to make additional determinations when reviewing research involving minor subjects. In addition to determining which category of pediatric research a particular project fits into, the IRB must affirmatively determine how many parental signatures are required on the study’s informed consent/parental permission form. The three* categories are: Category […]

Filed Under: Institutional Review Board Members

There’s a new blog quiz available

We’re feeling pretty darn proud of ourselves over here at IRB Blog Central. We got the second quarter IRB Blog quiz out and posted well before the second quarter was over. There are now two quizzes available at learnondemand.org. Access them both by going to the highlighted link and typing “IRB” into the search box […]

Filed Under: Institutional Review Board Members

New review options from the Office of Research Compliance

The UAMS Office of Research Compliance announces some new review and feedback opportunities for the UAMS research community: Contact the ORC for more information or to request a review.  

Filed Under: Institutional Review Board Members

New IRB Policy 1.4 posted

The IRB has revised its policy 1.4, titled Studies Requiring Review and Human Research Determinations. This policy describes the UAMS IRB’s review and oversight responsibilities, its ability to cede those responsibilities when applicable, and the process for determining whether a project is human subject research requiring IRB review. The more notable changes include adding a definition […]

Filed Under: Institutional Review Board Members

More updates to the FDA guidance on clinical trials during Covid-19

The FDA continue to set speed records in drafting and updating guidances as the Covid-19 pandemic continues. The agency has again updated its guidance titled FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency.  The changes were made to the Q&A section at the end of the guidance. “The updated […]

Filed Under: Institutional Review Board Members

Documenting atypical consent processes

All consent process that involve direct interaction with subjects should be documented with a separate note in the research record, according to IRB Policy 15.5. This extra documentation requirement takes on greater importance in situations like that presented by Covid-19. If your study is enrolling Covid-19 patients, you may not want to put study staff […]

Filed Under: Institutional Review Board Members

OHRP Guidance on Covid-19

The federal Office for Human Research Protections has released guidance about research subject to the Common Rule under Covid-19. We took a quick look at it and are relieved to note it accords with what we’ve been telling people about current goings-on. Read it straight from the source here.

Filed Under: Institutional Review Board Members

  • «Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Interim pages omitted …
  • Page 72
  • Next Page»
University of Arkansas for Medical Sciences LogoUniversity of Arkansas for Medical SciencesUniversity of Arkansas for Medical Sciences
Mailing Address: 4301 West Markham Street, Little Rock, AR 72205
Phone: (501) 686-7000
  • Facebook
  • X
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement
  • Legal Notices

© 2026 University of Arkansas for Medical Sciences